From December 7, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for $0 million under the buyback announced on December 7, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
87.29 USD | -0.43% | -0.96% | +14.48% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.48% | 52.6B | |
+7.77% | 218B | |
+10.16% | 189B | |
+26.21% | 151B | |
+32.78% | 113B | |
+1.98% | 64.02B | |
+2.92% | 49.85B | |
-6.60% | 37.89B | |
-1.07% | 34.92B | |
+23.08% | 31.1B |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Tranche Update on Edwards Lifesciences Corporation (NYSE: EW)'s Equity Buyback Plan announced on December 7, 2023.